Imbruvica (ibrutinib)

pCPA File Number: 20807
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Sponsor/Manufacturer:
Janssen Inc.
CDA-AMC Project Number:
PC0043-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: